Follow
Michael H. Parker
Michael H. Parker
Fox Chase Chemical Diversity Center; PDDI; Janssen/Johnson & Johnson
Verified email at fctdi.com
Title
Cited by
Cited by
Year
Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers
GH Posner, P Ploypradith, MH Parker, H O'dowd, SH Woo, J Northrop, ...
Journal of medicinal chemistry 42 (21), 4275-4280, 1999
1941999
Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers
GH Posner, P Ploypradith, MH Parker, H O'dowd, SH Woo, J Northrop, ...
Journal of medicinal chemistry 42 (21), 4275-4280, 1999
1921999
Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers
GH Posner, P Ploypradith, MH Parker, H O'Dowd, SH Woo, J Northrop, ...
Journal of medicinal chemistry 42 (21), 4275-4280, 1999
1921999
2-Amino-3, 4-dihydroquinazolines as inhibitors of BACE-1 (β-site APP cleaving enzyme): use of structure based design to convert a micromolar hit into a nanomolar lead
EW Baxter, KA Conway, L Kennis, F Bischoff, MH Mercken, HL De Winter, ...
Journal of medicinal chemistry 50 (18), 4261-4264, 2007
1842007
Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family
GH Posner, MH Parker, J Northrop, JS Elias, P Ploypradith, S Xie, ...
Journal of medicinal chemistry 42 (2), 300-304, 1999
1371999
The role of sulfamide derivatives in medicinal chemistry: a patent review (2006–2008)
AB Reitz, GR Smith, MH Parker
Expert opinion on therapeutic patents 19 (10), 1449-1453, 2009
922009
Antimalarial simplified 3-aryltrioxanes: synthesis and preclinical efficacy/toxicity testing in rodents
GH Posner, HB Jeon, MH Parker, M Krasavin, IH Paik, TA Shapiro
Journal of medicinal chemistry 44 (19), 3054-3058, 2001
722001
Direct conversion of Pyranose anomeric OH→ F→ R in the Artemisinin Family of Antimalarial Trioxanes
SH Woo, MH Parker, P Ploypradith, J Northrop, GH Posner
Tetrahedron letters 39 (12), 1533-1536, 1998
671998
Synthesis of (−)-5, 8-Dihydroxy-3R-methyl-2R-(dipropylamino)-1, 2, 3, 4-tetrahydronaphthalene: An Inhibitor of β-Amyloid 1–42 Aggregation
MH Parker, R Chen, KA Conway, DHS Lee, C Luo, RE Boyd, SO Nortey, ...
Bioorganic & medicinal chemistry 10 (11), 3565-3569, 2002
412002
Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo [b] thien-3-yl) methyl) sulfamide (JNJ-26990990) into human clinical studies
MH Parker, VL Smith-Swintosky, DF McComsey, Y Huang, D Brenneman, ...
Journal of medicinal chemistry 52 (23), 7528-7536, 2009
382009
Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads
Y Huang, ED Strobel, CY Ho, CH Reynolds, KA Conway, JA Piesvaux, ...
Bioorganic & medicinal chemistry letters 20 (10), 3158-3160, 2010
362010
Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy
T Lu, C Schubert, MD Cummings, G Bignan, PJ Connolly, K Smans, ...
Bioorganic & medicinal chemistry letters 28 (12), 2159-2164, 2018
332018
CO-THERAPY FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
VL Smith-swintosky, MH Parker, AB Reitz, BE Maryanoff, DF Mccomsey
EP Patent 2,026,790, 2009
32*2009
NOVEL BENZO-FUSED HETEROARYL SULFAMIDE DERIVATIVES USEFUL AS ANTICONVULSANT AGENTS
MH Parker, AB Reitz, BE Maryanoff
EP Patent 1,794,143, 2008
322008
Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
MH Parker, AB Reitz, BE Maryanoff
US Patent App. 11/209,122, 2005
322005
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
DF McComsey, MH Parker, AB Reitz, BE Maryanoff
US Patent App. 11/154,386, 2005
322005
Synthesis of Several Naturally Occurring Polyhalogenated Monoterpenes of the Halomon Class1
ME Jung, MH Parker
The Journal of Organic Chemistry 62 (21), 7094-7095, 1997
311997
Co-therapy for the treatment of epilepsy and related disorders
VL Smith-Swintosky, DF Mccomsey, MH Parker, AB Reitz, BE Maryanoff
US Patent 8,853,263, 2014
262014
Co-therapy for the treatment of epilepsy and related disorders
VL Smith-Swintosky, DF Mccomsey, MH Parker, AB Reitz, BE Maryanoff
US Patent 8,853,263, 2014
262014
Novel, Broad-Spectrum Anticonvulsants Containing a Sulfamide Group: Pharmacological Properties of (S)-N-[(6-Chloro-2, 3-dihydrobenzo [1, 4] dioxin-2-yl) methyl] sulfamide (JNJ …
DF McComsey, VL Smith-Swintosky, MH Parker, DE Brenneman, ...
Journal of medicinal chemistry 56 (22), 9019-9030, 2013
262013
The system can't perform the operation now. Try again later.
Articles 1–20